Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,082 public trials 2,050 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Open-label Extended Access Program on Lenalidomide Plus Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma Who Participated in CC-5013-MM021 for at Least 1 Year

NCT02348528

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Peking University Third Hospital Beijing, China
  • Peking Union Medical College Hospital Beijing, China
  • The 301 Hospital-Chinese PLA General Hospital Beijing, China
  • Xiangya Hospital of Central South University Changsha, China
View Trial Details
Completed

Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma

NCT00555100

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • National Hospital Organization Nagoya Medical Center Nagoya, Aichi-ken, Japan
  • Jichi Medical University Hospital Shimotsuke, Tochigi, Japan
  • Niigata Cancer Center Hospital Niigata, Japan
View Trial Details
Completed

A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma

NCT01169298

Conditions
Adult T-Cell Leukemia-Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
Locations
  • National Kyusyu Cancer Center Fukuoka, Japan
  • Imamura Bun-in Hospital Kagoshima, Japan
  • Kumamoto University Hospital Kumamoto, Japan
  • Nagasaki University Hospital Nagasaki, Japan
View Trial Details
Completed

Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma

NCT00761722

Conditions
Acute Myeloid Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +26 more
Locations
  • California Cancer Care Inc Greenbrae, California, United States
  • Main Cancer Centers of Florida, P.A. Ocoee, Florida, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
View Trial Details
Completed

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

NCT01351935

Conditions
B Cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +26 more
Locations
  • Clearview Cancer Institute Oncology Specialties, P.C Huntsville, Alabama, United States
  • University of Arizona SPORE Tucson, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
View all 13 locations
View Trial Details
Completed

A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia

NCT00419250

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
  • Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States
  • Baptist Cancer Institute Jacksonville, Florida, United States
View all 35 locations
View Trial Details

Related conditions